VRTX
Asset Logo

Vertex Pharmaceuticals Incorporated

🇺🇸 NYSE/NASDAQ

📈 HIGH PRICE GROWTH

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

+ 15.99%
Annual Growth

5 years average annual growth

🌏

7
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Vertex Pharmaceuticals Incorporated is a global biotechnology company. The Company is focused on investing in scientific innovation to create transformative medicines for people with serious diseases, with a focus on specialty markets. It has four approved medicines that treat the underlying cause of cystic fibrosis (CF), and one approved therapy that treats severe sickle cell disease (SCD) and transfusion dependent beta thalassemia (TDT). Its pipeline includes clinical-stage programs in CF, SCD, TDT, acute and neuropathic pain, APOL1-mediated kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency. Its marketed medicines are TRIKAFTA/KAFTRIO, SYMDEKO/SYMKEVI (tezacaftor/ivacaftor and ivacaftor), ORKAMBI (lumacaftor/ivacaftor) and KALYDECO (ivacaftor). It is developing non-autologous (allogeneic) fully differentiated, stem-cell derived islet cell therapies designed to replace insulin-producing islet cells that are destroyed in people with T1D.

📈 Performance

Price History*

+234.15%

1M

1Y

10Y

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$397.27

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in VRTX

7

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

26 weeks

💵 Average investment amount

$1,120

Last time a customer invested in VRTX

10 days
VRTX investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

71%

50k - 100k

29%

Less than 50k

👶 Age of investors

18 - 25

14%

26 - 34

43%

35 - 90

43%
🙋 Legal gender of investors

Female

43%

Male

57%

Pearlers who invest in VRTX also invest in...

NVIDIA Corporation

NVDA

🙌 Performance (5Yr p.a)

430.24%

📊 Share price

$134.70 USD

📈 HIGH PRICE GROWTH

Find Out More

🙌 Performance (5Yr p.a)

35.48%

📊 Share price

$436.60 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

52.94%

📊 Share price

$254.49 USD

🙌 Performance (5Yr p.a)

987.15%

📊 Share price

$224.92 USD

🙌 Performance (5Yr p.a)

538.65%

📊 Share price

$108.95 USD

Want more shares? Try these...

📊 Share price

$2.19 USD

🙌 Performance (5Yr p.a)

15.91%

📊 Share price

$221.00 USD

📈 HIGH PRICE GROWTH

Compare
Add to watchlist